U.S. Markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
79.97+0.14 (+0.18%)
At close: 4:00PM EDT

79.68 -0.29 (-0.37%)
After hours: 4:11PM EDT

People also watch
BMRNACORSGENACADALXN
Full screen
Previous Close79.83
Open80.50
Bid0.00 x
Ask0.00 x
Day's Range78.69 - 80.88
52 Week Range31.38 - 86.92
Volume1,082,066
Avg. Volume1,035,320
Market Cap7.32B
Beta3.47
PE Ratio (TTM)-16.55
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 5 Biotech Stocks With Major Catalysts in July
    Motley Fool7 hours ago

    5 Biotech Stocks With Major Catalysts in July

    Big news is on the way soon for AcelRx, Alnylam, Amgen, Dynavax, and Merck.

  • Barrons.com16 hours ago

    [$$] Alnylam Selloff Looks Like an Overreaction

    Alnylam Pharmaceuticals (ALNY:Nasdaq) By Credit Suisse ($85.21, June 26, 2017) We are raising our target price on Alnylam Pharmaceuticals to $96 from $90 as we increased our probability of success from 40% to 60% in porphyria. At 100% success this adds $12 a share to our model (due to high operating leverage and modeling of fixed costs for the research platform). At 0% success to porphyria our discounted-cash-flow model is $18 a share lower at $78 a share.

  • 5 Best Biotech Stocks of 2017 So Far
    Motley Fool3 days ago

    5 Best Biotech Stocks of 2017 So Far

    How Alnylam, Puma, Immunogen, Sangamo, and Calithera beat all others to be the best biotech stocks of the year so far.